Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer
In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX
Breast Cancer Coalition Widens Its Agenda For Advocacy, Vows To Fight NIH Cutbacks
NCI’s Goal To Increase Minority Participation In Trials, Sondik Says
UT Southwestern, M.D. Anderson Form Cancer Center In Dallas
NCI Scientists Immunize A Healthy BMT Donor Against Myeloma
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Peter F. Garrett to people with cancer: Your story has power
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - What NHS-Galleri taught us—and what it didn’t
- The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies









